Vaccine adjuvant: it makes the difference
Authors:
- Sandra Aparecida dos SantosSSSandra Aparecida dos Santos
- José M. RodriguesJRJosé M. Rodrigues
- Célio L. SilvaCSCélio L. Silva
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunology of tuberculosis and implications in vaccine developmentTuberculosis, 2004
- Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-FosThe Journal of Immunology, 2003
- Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicityDrug Discovery Today, 2003
- Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primatesClinical Immunology, 2003
- Reproductive toxicity testing of vaccinesToxicology, 2003
- Vaccine adjuvant technology: from mechanistic concepts to practical applicationsExpert Review of Vaccines, 2003
- What are the limits of adjuvanticity?Vaccine, 2001
- Manipulating the immune system: humoral versus cell-mediated immunityAdvanced Drug Delivery Reviews, 2001
- Dendritic cells at the end of the MillenniumImmunology & Cell Biology, 1999
- Adjuvants—a classification and review of their modes of actionVaccine, 1997